Losartan to Improve Outcomes After Multi-ligament Knee Injury
Phase 2
Not yet recruiting
- Conditions
- Multi-ligament Knee Injury
- Interventions
- Drug: losartan 25 mgOther: Placebo capsule
- First Posted Date
- 2025-04-18
- Last Posted Date
- 2025-04-22
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 90
- Registration Number
- NCT06933706
- Locations
- 🇺🇸
Mass General Brigham, Foxborough, Massachusetts, United States
Mixed Vs Blocked Search: Four Unique Tasks
Not Applicable
Recruiting
- Conditions
- VisionHealthyAttention
- First Posted Date
- 2025-04-18
- Last Posted Date
- 2025-04-21
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT06933693
- Locations
- 🇺🇸
Brigham & Women's Hospital, Boston, Massachusetts, United States
Emulation of the STEP-HFpEF DM Heart Failure Trial in Healthcare Claims Data
Active, not recruiting
- Conditions
- Diabetes Mellitus, Type 2HFpEF - Heart Failure With Preserved Ejection Fraction
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-04-06
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 58387
- Registration Number
- NCT06914102
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Emulation of the SUMMIT Heart Failure Trial in Healthcare Claims Data
Active, not recruiting
- Conditions
- Diabetes Mellitus, Type 2Heart Failure With Preserved Ejection Fraction (HFPEF)
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-04-06
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 11265
- Registration Number
- NCT06914154
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Comparative Effectiveness of Tirzepatide Versus Semaglutide in Individuals With Heart Failure With Preserved Ejection Fraction
Active, not recruiting
- Conditions
- Diabetes Mellitus, Type 2HFpEF - Heart Failure With Preserved Ejection Fraction
- Interventions
- First Posted Date
- 2025-04-06
- Last Posted Date
- 2025-05-22
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 28118
- Registration Number
- NCT06914141
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Community-Based Engagement to Improve Lung Cancer Screening and Outcomes
Not Applicable
Not yet recruiting
- Conditions
- Lung Cancer Screening
- First Posted Date
- 2025-04-04
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 75
- Registration Number
- NCT06909981
Self-Directed Positive Psychology Intervention for Newly Diagnosed Multiple Sclerosis
Not Applicable
Completed
- Conditions
- Multiple Sclerosis
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-28
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06891937
- Locations
- 🇺🇸
Brigham MS Center, Boston, Massachusetts, United States
A Phase 2a Study of Foralumab Nasal in Patients with Multiple System Atrophy (MSA)
Phase 2
Not yet recruiting
- Conditions
- Multiple System Atrophy
- Interventions
- Drug: Foralumab Nasal
- First Posted Date
- 2025-03-11
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 5
- Registration Number
- NCT06868628
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
The Multicenter Stress Cardiac Magnetic Resonance Quantitative Perfusion Imaging in the United States Study
Not Applicable
Not yet recruiting
- Conditions
- Ischemic Heart Disease (IHD)Cardiac Magnetic Resonance ImagingMyocardial Blood Flow
- Interventions
- Diagnostic Test: Qualitative Myocardial Blood Flow EvaluationDiagnostic Test: Quantitative Myocardial Blood Flow EvaluationDrug: VasodilatorDiagnostic Test: Blood draw for the laboratory assessment
- First Posted Date
- 2025-03-03
- Last Posted Date
- 2025-03-03
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 1000
- Registration Number
- NCT06854458
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Impacts of Opioids on Respiratory Drive During Sleep
Early Phase 1
Not yet recruiting
- Conditions
- OpioidsObstructive Sleep Apnea (OSA)
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-03-03
- Last Posted Date
- 2025-03-03
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 26
- Registration Number
- NCT06854211
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath